|
|
Volumn 344, Issue 14, 2001, Pages 1052-1056
|
|
Effect of the tyrosine kinase inhibitor STI571 in a patient with a metastatic gastrointestinal stromal tumor
a
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
DACARBAZINE;
DOXORUBICIN;
IFOSFAMIDE;
IMATINIB;
MESNA;
PROTEIN TYROSINE KINASE INHIBITOR;
ABDOMINAL MASS;
ADULT;
ARTICLE;
CANCER CHEMOTHERAPY;
CASE REPORT;
DISEASE COURSE;
DRUG EFFECT;
ENZYME ACTIVITY;
FEMALE;
GASTROINTESTINAL TUMOR;
HUMAN;
IMMUNOHISTOCHEMISTRY;
METASTASIS;
NUCLEAR MAGNETIC RESONANCE IMAGING;
POSITRON EMISSION TOMOGRAPHY;
PRIORITY JOURNAL;
SIDE EFFECT;
STROMA;
TUMOR REGRESSION;
TUMOR VOLUME;
ANTINEOPLASTIC AGENTS;
ENZYME INHIBITORS;
FEMALE;
FLUORODEOXYGLUCOSE F18;
FUSION PROTEINS, BCR-ABL;
HUMANS;
LIVER NEOPLASMS;
MAGNETIC RESONANCE IMAGING;
MIDDLE AGED;
NEOPLASM RECURRENCE, LOCAL;
PIPERAZINES;
PROTEIN-TYROSINE KINASES;
PYRIMIDINES;
SARCOMA;
STOMACH NEOPLASMS;
STROMAL CELLS;
TOMOGRAPHY, EMISSION-COMPUTED;
|
|
EID: 0035810148
PISSN: 00284793
EISSN: None
Source Type: Journal
DOI: 10.1056/NEJM200104053441404 Document Type: Article |
|
Times cited : (1880)
|
|
References (10)
|
